Monday, 31 August 2026European Markets

LECTRA And 2 Other Stocks Have Very High Payout Ratio

Loading stream...

(vianews) - elkem (elk.ol), europris (epr.ol), lectra (lss.pa) are the highest payout ratio stocks on this list.

here's the data we've collected of stocks with a high payout ratio as yet. the payout ratio in itself isn't a guarantee of a future good investment but it's an indicator of whether dividends are being paid and how the company chooses to distribute them.

when researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. elkem (elk.ol)

77.32% payout ratio

earnings per share

as for profitability, elkem has a trailing twelve months eps of kr-0.8.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.37%.

volume

today's last reported volume for elkem is 684841 which is 33.3% below its average volume of 1026850.

more news about elkem.

2. europris (epr.ol)

47.25% payout ratio

earnings per share

as for profitability, europris has a trailing twelve months eps of kr5.53.

pe ratio

europris has a trailing twelve months price to earnings ratio of 12.41. meaning, the purchaser of the share is investing kr12.41 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 33.76%.

dividend yield

according to morningstar, inc., the next dividend payment is on apr 21, 2023, the estimated forward annual dividend rate is 2.75 and the estimated forward annual dividend yield is 4.44%.

moving average

europris's worth is above its 50-day moving average of kr65.90 and higher than its 200-day moving average of kr68.39.

more news about europris.

3. lectra (lss.pa)

42.86% payout ratio

earnings per share

as for profitability, lectra has a trailing twelve months eps of €0.91.

pe ratio

lectra has a trailing twelve months price to earnings ratio of 35.55. meaning, the purchaser of the share is investing €35.55 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.07%.

revenue growth

year-on-year quarterly revenue growth grew by 14.5%, now sitting on 500.31m for the twelve trailing months.

dividend yield

as stated by morningstar, inc., the next dividend payment is on apr 30, 2024, the estimated forward annual dividend rate is 0.36 and the estimated forward annual dividend yield is 1.32%.

yearly top and bottom value

lectra's stock is valued at €32.35 at 16:10 est, under its 52-week high of €35.20 and way higher than its 52-week low of €19.92.

more news about lectra.

1. 1 (1)

1% payout ratio

1

earnings per share

as for profitability, 1 has a trailing twelve months eps of €1.

pe ratio

1 has a trailing twelve months price to earnings ratio of 1. meaning, the purchaser of the share is investing €1 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 1%.

volume

today's last reported volume for 1 is 1 which is 1% above its average volume of 1.

growth estimates quarters

the company's growth estimates for the ongoing quarter and the next is 1% and 1%, respectively.

more news about 1.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com